Karbach J, Gnjatic S, Bender A, Neumann A, Weidmann E, Yuan J, et al. Tumor- reactive CD8 þT-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival. Int J Cancer 2010;126: 909 –18. 21. Reuschenbach M, Pauligk C, Karbach J, Ra ﬁyan MR, Kloor M, Prigge ES, et al. A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptideFrameshift Peptide Vaccine for MSI Cancer AACRJournals.org Clin Cancer Res; 26(17) September 1, 2020 4509Downloaded from http://aacrjournals.org/clincancerres/article-pdf/26/17/4503/2062752/4503.pdf by guest on 29 November 2024 vaccine in patients with advanced human papillomavirus-associated cancers. Cancer 2016;122:1425 –33.